BRIEF-Epizyme's investigational new drug application gets FDA nod
May 04, 2016 at 06:48 AM EDT
* Epizyme announces fda acceptance of investigational new drug application for tazemetostat in mesothelioma
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.